COHEN RAYMOND W Insider Trading Activity (RXST)

Summary

Updated Jul 16, 2026

COHEN RAYMOND W has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $489K.

Profile

Raymond W. Cohen is the Chief Executive Officer of RxSight, Inc., a medical technology company focused on improving vision after cataract surgery. He has held executive roles in various companies, including Axonics, Inc. and Kestra Medical Technologies, Ltd.

Role	Insider
Notability	30/100

Board memberships

RxSight, Inc.
Axonics, Inc.
Kestra Medical Technologies, Ltd.

Awards & honors

CEO of RxSight, Inc.
Leadership in medical technology sector
Experience in executive roles across multiple companies

Recent Transactions

Date	Ticker	Company	Code	Shares	Price	Value
2026-06-18	RXST	RxSight, Inc.	A — Grant or award	30.9K	—
2026-03-30	KMTS	KESTRA MEDICAL TECHNOLOGIES, LTD.	P — Open-market purchase	10.0K	$19.98	$200K
2026-01-16	NSPR	InspireMD, Inc.	A — Grant or award	44.0K	$0.00
2025-07-31	RXST	RxSight, Inc.	A — Grant or award	35.7K	$0.00
2025-07-24	KMTS	KESTRA MEDICAL TECHNOLOGIES, LTD.	A — Grant or award	13.0K	—
2025-03-07	KMTS	KESTRA MEDICAL TECHNOLOGIES, LTD.	A — Grant or award	10.9K	—
2025-03-07	KMTS	KESTRA MEDICAL TECHNOLOGIES, LTD.	P — Open-market purchase	17.0K	$17.00	$289K
2024-11-15	AXNX	Axonics, Inc.	D — Derivative transaction	292.7K	$71.00	$20.78M

Frequently Asked Questions

Who is COHEN RAYMOND W?

How many SEC Form 4 filings has COHEN RAYMOND W submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has COHEN RAYMOND W been buying or selling stock?

Recorded transactions: 2 open-market purchases ($489K) and 0 open-market sales () across all tracked filings.

Where can I see all of COHEN RAYMOND W's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

COHEN RAYMOND W — SEC Form 4 Insider Trading Activity